Displaying 201 - 250 of 4673 results
Released Company Title Industry Topic
27 Sep 2023
07:30 CEST
GENSIGHT BIOLOGICS GenSight Biologics fait un point sur l’avis scientifique de l’Agence européenne des médicaments pour LUMEVOQ® 20103010 Biotechnology Corporate life
27 Sep 2023
07:30 CEST
ARKEMA ARKEMA DÉVOILE SON AMBITION 2028 ET ACCÉLÈRE SA CROISSANCE ORGANIQUE DANS LES MATÉRIAUX DE HAUTE PERFORMANCE ET LES SOLUTIONS DURABLES 55201000 Chemicals: Diversified Other subject
27 Sep 2023
07:30 CEST
ONWARD MEDICAL ONWARD® kündigt die erste Implantation eines ARC-IM™-Stimulators mit Gehirn-Computer-Schnittstelle (BCI) beim Menschen an, um die Arm-, Hand- und Fingerfunktion nach einer Rückenmarksverletzung wiederherzustellen 20101025 Health Services -
27 Sep 2023
07:30 CEST
GENEURO Une nouvelle étude publiée dans PNAS confirme le rôle neuropathogène de la protéine HERV-W dans la sclérose en plaques. 20103010 Biotechnology Other subject
27 Sep 2023
07:30 CEST
THERAVET TheraVet: Patient Recruitment Phase Successfully Completed in BIOCERA-VET Fracture Revision Surgery Study in Toy Dogs 20103015 Pharmaceuticals Other subject
27 Sep 2023
07:30 CEST
VOLTALIA Voltalia SA: Half-Year 2023 65101010 Alternative Electricity Other subject
27 Sep 2023
07:30 CEST
GENSIGHT BIOLOGICS GenSight Biologics Provides Update on European Medicines Agency Scientific Advice for LUMEVOQ® 20103010 Biotechnology Corporate life
27 Sep 2023
07:27 CEST
NORSK SOLAR AS Norsk Solar, pioneers in Brazil with the inauguration of its first photovoltaic plants 65101010 Alternative Electricity Inside information
27 Sep 2023
07:00 CEST
BIOSENIC BioSenic performs further analysis of its phase 2 clinical trial data, leading to an optimal administration scheme for its next late-stage trial of arsenic trioxide in cGvHD 20103010 Biotechnology Other subject
27 Sep 2023
07:00 CEST
CAMBI ASA Cambi ASA: Capital Markets Update presentation 50202030 Electronic Equipment: Pollution Control Additional regulated information required to be disclosed under the laws of a Member State
27 Sep 2023
07:00 CEST
BIOSENIC BioSenic poursuit l'analyse des données de son essai clinique de phase 2, ce qui lui permet de définir un schéma d'administration optimal pour son prochain essai de phase avancée sur l'arsenic trioxide dans le traitement de la cGvHD 20103010 Biotechnology Other subject
27 Sep 2023
07:00 CEST
IMCD IMCD Korea enhances growth momentum in the coatings and construction market with the acquisition of Needfill 55201020 Specialty Chemicals -
27 Sep 2023
07:00 CEST
ENSURGE MICROPOWER ASA Ensurge Micropower ASA to host a Company update presentation with the Chairman of the Board 50202040 Electronic Equipment: Other Non-regulatory press releases
27 Sep 2023
07:00 CEST
MITHRA Mithra Announces Presentation of Positive Data on Estetrol (E4) Native Estrogen at NAMS 2023 20103015 Pharmaceuticals -
27 Sep 2023
00:34 CEST
FRANCAISE ENERGIE Biogy Solutions AS : un nouvel acteur ambitieux sur le marché norvégien du Biogaz et du Bio-CO2 65101010 Alternative Electricity New
27 Sep 2023
00:34 CEST
FRANCAISE ENERGIE Biogy Solutions AS: An Ambitious Player to the Norwegian Biogas and Bio-CO2 Market 65101010 Alternative Electricity New
26 Sep 2023
23:37 CEST
NEXT BIOMETRICS GROUP NEXT Biometrics Group ASA – Private Placement successfully placed 10102015 Electronic Components Inside information
26 Sep 2023
23:33 CEST
NEXT BIOMETRICS GROUP NEXT Biometrics Group ASA – Private Placement successfully placed 10102015 Electronic Components Inside information
26 Sep 2023
23:20 CEST
SHELF DRILLING Shelf Drilling Private Placement Successfully Placed 60101030 Oil Equipment and Services Inside information
26 Sep 2023
22:46 CEST
MDXHEALTH Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer 20103010 Biotechnology Commercial operations
26 Sep 2023
22:46 CEST
MDXHEALTH Mdxhealth signe une collaboration de recherche avec l'Université d'Oxford pour évaluer la corrélation entre le test GPS et la progression du cancer de la prostate après un traitement pour un cancer de la prostate localisé 20103010 Biotechnology Commercial operations
26 Sep 2023
22:34 CEST
PHAXIAM THERAPEUTICS RAPPORT FINANCIER SEMESTRIEL 30 JUIN 2023 PHAXIAM 20103010 Biotechnology Legal
26 Sep 2023
22:34 CEST
PHAXIAM THERAPEUTICS Rapport Financier Semestriel 30 Juin 2023 PHAXIAM 20103010 Biotechnology Legal
26 Sep 2023
22:25 CEST
Q-FREE Guardian Smart Infrastructure Management and Rieber & Søn AS Announce Joint Venture to Purchase Q-Free ASA shares at NOK 12.00 per share 50202020 Electronic Equipment: Control and Filter Inside information
26 Sep 2023
22:15 CEST
NANOBIOTIX NANOBIOTIX fait le point sur ses activités et publie ses résultats financiers pour le premier semestre 2023 20103010 Biotechnology Commercial results
26 Sep 2023
22:15 CEST
NANOBIOTIX NANOBIOTIX Provides Business Update and Financial Results for the First Half of 2023 20103010 Biotechnology Commercial results
26 Sep 2023
22:10 CEST
GENFIT GENFIT Announces Publication in Nature Medicine Confirming the Performance of its NASH Diagnostic Technology   20103010 Biotechnology Other subject
26 Sep 2023
22:10 CEST
GENFIT GENFIT annonce une publication dans Nature Medicine confirmant la performance de sa technologie de diagnostic dans la NASH 20103010 Biotechnology Other subject
26 Sep 2023
21:30 CEST
NORDEA BANK Nordea Bank Abp: Repurchase of own shares on 26.09.2023 30101010 Banks Acquisition or disposal of the issuer’s own shares
26 Sep 2023
21:25 CEST
Jotta Group AS 21/25 FRN FLOOR C Hawk Infinity Software AS - Call notice ISIN NO0010998586 and temp. ISIN NO0012899378 - Annen informasjonspliktig regulatorisk informasjon
26 Sep 2023
20:55 CEST
PERSHING SQUARE HOLDING Pershing Square Holdings, Ltd. Announces Transactions in Own Shares - 26 September 2023 30204000 Closed End Investments Other subject
26 Sep 2023
20:00 CEST
ABIONYX PHARMA ABIONYX Pharma Announces Its 2023 Half-Year Financial Results 20103010 Biotechnology Income
26 Sep 2023
20:00 CEST
ABIONYX PHARMA ABIONYX Pharma annonce ses résultats financiers du 1er semestre 2023 20103010 Biotechnology Income
26 Sep 2023
20:00 CEST
SOPRA STERIA GROUP Percentage of Shares Tendered Under Sopra Steria's Offer for Ordina at 92.73% 10101010 Computer Services Other subject
26 Sep 2023
19:21 CEST
SHELL PLC Transaction in Own Shares 60101000 Integrated Oil and Gas Other subject
26 Sep 2023
19:20 CEST
NEL Nel ASA: Nel has selected Plymouth in Michigan for its next gigafactory 60102020 Renewable Energy Equipment Non-regulatory press releases
26 Sep 2023
19:11 CEST
BIO-UV GROUP Réactivation du programme de rachat d'actions 50202020 Electronic Equipment: Control and Filter Other subject
26 Sep 2023
18:42 CEST
Telenor ASA Telenor ASA - Issuance of bonds 15102015 Telecommunications Services Non-regulatory press releases
26 Sep 2023
18:34 CEST
TELEPERFORMANCE Teleperformance SE : Déclaration des transactions sur actions propres réalisées le 26 septembre 2023 50205020 Professional Business Support Services Share history
26 Sep 2023
18:34 CEST
TELEPERFORMANCE Teleperformance SE: Statement on Transactions on Own Shares Carried out on September 26, 2023 50205020 Professional Business Support Services Share history
26 Sep 2023
18:31 CEST
RENAULT Renault Group: The Alliance’s model is evolving towards a more efficient and agile project-driven cooperation 40101020 Automobiles Other subject
26 Sep 2023
18:31 CEST
RENAULT Renault Group : L’Alliance évolue vers une coopération plus efficace et plus agile, axée sur les projets 40101020 Automobiles Other subject
26 Sep 2023
18:30 CEST
PERNOD RICARD Filing of Pernod Ricard’s 2022/23 Universal registration document 45101015 Distillers and Vintners Other subject
26 Sep 2023
18:30 CEST
PERNOD RICARD Mise à disposition du Document d’enregistrement universel Pernod Ricard 2022/23 45101015 Distillers and Vintners Other subject
26 Sep 2023
18:25 CEST
FOCUS ENTERTAINMENT FOCUS ENTERTAINMENT: Line-up execution update as of September 2023 40203040 Electronic Entertainment New
26 Sep 2023
18:25 CEST
FOCUS ENTERTAINMENT FOCUS ENTERTAINMENT : Point d’étape sur l’exécution du line up à fin septembre 2023 40203040 Electronic Entertainment New
26 Sep 2023
18:15 CEST
THE AZUR SELECTION S.A. Azur Selection S.A. Announces Its Half-Year Results for 2023 and Provides an Update on Its Hotel Project in the Peloponnese Greece 40501025 Hotels and Motels Income
26 Sep 2023
18:15 CEST
THE AZUR SELECTION S.A. Azur Selection S.A. annonce ses résultats semestriels 2023 et fait le point sur son projet hôtelier dans le Péloponnèse 40501025 Hotels and Motels Income
26 Sep 2023
18:08 CEST
SHELL PLC Director/PDMR Shareholding 60101000 Integrated Oil and Gas Other subject
26 Sep 2023
18:00 CEST
BOA CONCEPT BOA CONCEPT: RESULTATS SEMESTRIELS 2023 50204000 Machinery: Industrial Income